Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ketogenic cancer:

Rationale, Feasibility and Acceptability of Ketogenic Diet for Cancer Treatment. Chung HY et al. J Cancer Prev. (2017)

Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer. Vergati M et al. Curr Med Chem. (2017)

Ketogenic diets: from cancer to mitochondrial diseases and beyond. Branco AF et al. Eur J Clin Invest. (2016)

Search results

Items: 1 to 20 of 319

1.

Keto microbiota: A powerful contributor to host disease recovery.

Cabrera-Mulero A, Tinahones A, Bandera B, Moreno-Indias I, Macías-González M, Tinahones FJ.

Rev Endocr Metab Disord. 2019 Nov 13. doi: 10.1007/s11154-019-09518-8. [Epub ahead of print] Review.

PMID:
31720986
2.

The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide.

Muscogiuri G, Barrea L, Laudisio D, Pugliese G, Salzano C, Savastano S, Colao A.

J Transl Med. 2019 Oct 29;17(1):356. doi: 10.1186/s12967-019-2104-z. Review.

3.

Multi-dimensional roles of ketone bodies in cancer biology: Opportunities for cancer therapy.

Feng S, Wang H, Liu J, Aa J, Zhou F, Wang G.

Pharmacol Res. 2019 Oct 16:104500. doi: 10.1016/j.phrs.2019.104500. [Epub ahead of print] Review.

PMID:
31629092
4.

Ketogenic Diet: A New Light Shining on Old but Gold Biochemistry.

Longo R, Peri C, Cricrì D, Coppi L, Caruso D, Mitro N, De Fabiani E, Crestani M.

Nutrients. 2019 Oct 17;11(10). pii: E2497. doi: 10.3390/nu11102497. Review.

5.

Pseudodiabetes-not a contraindication for metabolic interventions.

Bravo-San Pedro JM, Sica V, Kroemer G.

Cell Death Dis. 2019 Oct 10;10(10):765. doi: 10.1038/s41419-019-2007-1.

6.

Underweight and weight loss are predictors of poor outcome in patients with brain metastasis.

Lareida A, Terziev R, Grossenbacher B, Andratschke N, Roth P, Rohrmann S, Stahel R, Guckenberger M, Le Rhun E, Weller M, Wolpert F.

J Neurooncol. 2019 Sep 30. doi: 10.1007/s11060-019-03300-1. [Epub ahead of print]

PMID:
31571112
7.

Naturopathic Oncology Care for Pediatric Cancers: A Practice Survey.

Psihogios A, Ennis JK, Seely D.

Integr Cancer Ther. 2019 Jan-Dec;18:1534735419878504. doi: 10.1177/1534735419878504.

8.

Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal Cells.

Kim JT, Li C, Weiss HL, Zhou Y, Liu C, Wang Q, Evers BM.

Cells. 2019 Sep 19;8(9). pii: E1106. doi: 10.3390/cells8091106.

10.

Ketogenic diet combined with antioxidant N-acetylcysteine inhibits tumor growth in a mouse model of anaplastic thyroid cancer.

Aggarwal A, Yuan Z, Barletta JA, Lorch JH, Nehs MA.

Surgery. 2019 Sep 11. pii: S0039-6060(19)30458-1. doi: 10.1016/j.surg.2019.06.042. [Epub ahead of print]

PMID:
31521320
11.

Patched1 haploinsufficiency severely impacts intermediary metabolism in the skin of Ptch1+/-/ODC transgenic mice.

Li C, Mishra B, Kashyap M, Weng Z, Andrabi SA, Mukhtar SM, Kim AL, Bickers DR, Kopelovich L, Athar M.

Sci Rep. 2019 Sep 10;9(1):13072. doi: 10.1038/s41598-019-49470-w.

12.

Ketogenic diet attenuates cerebellar atrophy progression in a subject with a biallelic variant at the ATAD3A locus [Response to Letter].

Al Madhoun A, Alnaser F, Melhem M, Nizam R, Al-Dabbous T, Al-Mulla F.

Appl Clin Genet. 2019 Aug 9;12:163-165. doi: 10.2147/TACG.S224520. eCollection 2019. No abstract available.

13.

Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: A Randomized Controlled Trial Study.

Khodabakhshi A, Akbari ME, Mirzaei HR, Mehrad-Majd H, Kalamian M, Davoodi SH.

Nutr Cancer. 2019 Sep 9:1-8. doi: 10.1080/01635581.2019.1650942. [Epub ahead of print]

PMID:
31496287
14.

In silico clinical trials for anti-aging therapies.

Menendez JA, Cuyàs E, Folguera-Blasco N, Verdura S, Martin-Castillo B, Joven J, Alarcón T.

Aging (Albany NY). 2019 Aug 24;11(16):6591-6601. doi: 10.18632/aging.102180. Epub 2019 Aug 24.

15.

Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to Diet.

Cheng CW, Biton M, Haber AL, Gunduz N, Eng G, Gaynor LT, Tripathi S, Calibasi-Kocal G, Rickelt S, Butty VL, Moreno-Serrano M, Iqbal AM, Bauer-Rowe KE, Imada S, Ulutas MS, Mylonas C, Whary MT, Levine SS, Basbinar Y, Hynes RO, Mino-Kenudson M, Deshpande V, Boyer LA, Fox JG, Terranova C, Rai K, Piwnica-Worms H, Mihaylova MM, Regev A, Yilmaz ÖH.

Cell. 2019 Aug 22;178(5):1115-1131.e15. doi: 10.1016/j.cell.2019.07.048.

PMID:
31442404
16.

Dietary restriction during the treatment of cancer: results of a systematic scoping review.

Shingler E, Perry R, Mitchell A, England C, Perks C, Herbert G, Ness A, Atkinson C.

BMC Cancer. 2019 Aug 15;19(1):811. doi: 10.1186/s12885-019-5931-7.

17.

p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas.

Hsieh MH, Choe JH, Gadhvi J, Kim YJ, Arguez MA, Palmer M, Gerold H, Nowak C, Do H, Mazambani S, Knighton JK, Cha M, Goodwin J, Kang MK, Jeong JY, Lee SY, Faubert B, Xuan Z, Abel ED, Scafoglio C, Shackelford DB, Minna JD, Singh PK, Shulaev V, Bleris L, Hoyt K, Kim J, Inoue M, DeBerardinis RJ, Kim TH, Kim JW.

Cell Rep. 2019 Aug 13;28(7):1860-1878.e9. doi: 10.1016/j.celrep.2019.07.027.

18.

Ketogenic diet in the treatment of cancer - Where do we stand?

Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B.

Mol Metab. 2019 Jul 27. pii: S2212-8778(19)30427-2. doi: 10.1016/j.molmet.2019.06.026. [Epub ahead of print] Review.

19.

Untargeted Metabolomics Reveals Molecular Effects of Ketogenic Diet on Healthy and Tumor Xenograft Mouse Models.

Licha D, Vidali S, Aminzadeh-Gohari S, Alka O, Breitkreuz L, Kohlbacher O, Reischl RJ, Feichtinger RG, Kofler B, Huber CG.

Int J Mol Sci. 2019 Aug 8;20(16). pii: E3873. doi: 10.3390/ijms20163873.

20.

The mystery of the ketogenic diet: benevolent pseudo-diabetes.

Blagosklonny MV.

Cell Cycle. 2019 Sep;18(18):2157-2163. doi: 10.1080/15384101.2019.1644765. Epub 2019 Aug 1.

Supplemental Content

Loading ...
Support Center